Online tools & resources

News and Events

demo_pricing_button      login_button

Release News

PharmaPendium 2013.2 Release

Wed, 10/04/2013

The content release includes the following updates:

Year-To-Date EMA and FDA approval documents statistics for 2013 (PP 2013.1 + PP 2013.2):

  • 3,597 new documents
  • 70,040 new pages
  • 27,206 new extracted PK data observations
  • 47,140 new extracted safety data observations
  • 14 new drugs

FDA Approval Packages:

  • 3 new drugs:
    • Cabozantinib
    • Ponatinib
    • Tofacitinib Citrate
  • 1,277 new FDA Approval Documents
  • 18,865 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

  • 527 new documents
  • 17,553 new pages

Extracted PK data observations:

  • 8,844 new extracted PK data lines

Extracted Safety data observations:

  • 14,333 new extracted safety data lines

Published Toxicity Database:

  • 930 new safety records

AERS (post-marketing) reports:

  • 127,978 new reports (2012_Q3 is added)


The new totals for PharmaPendium are:

  • 1,708,983 pages of FDA Approval documents (Including FDA Classic Collection)
  • 75,173 documents of FDA Approval documents (Including FDA Classic Collection)
  • 4,130 drugs with data in PharmaPendium
  • 1,228,016 extracted safety data lines
  • 1,320,572 extracted PK data lines
  • 5,259,022 AERS (post-marketing) reports
  • 6,002 documents / 107,300 pages of EMA Approval documents
  • 11,842 documents / 491,869 pages of FDA Advisory Committee Meeting documents
  • 10,906 documents / 308,015 pages of FDA Classic Collection

Newsletter